Austin, TX, United States of America

Andreas Bader

USPTO Granted Patents = 4 

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2011-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Andreas Bader

Introduction

Andreas Bader is a notable inventor based in Austin, TX, who has made significant contributions to the field of biotechnology. With a total of four patents to his name, Bader's work focuses on innovative therapies and molecular technologies that have the potential to impact medical treatments.

Latest Patents

Bader's latest patents include the development of Claudin 18.2 T cell-antigen couplers and their applications. These couplers consist of polypeptides that feature an antigen-binding domain targeting Claudin 18.2, another domain that binds a protein associated with a T cell receptor complex, and a T cell receptor signaling domain. Additionally, he has patented a method for treating liver cancer using a combination of sorafenib and synthetic oligonucleotides, which enhances therapeutic efficacy through a specific molar ratio.

Career Highlights

Throughout his career, Bader has worked with prominent companies in the biotechnology sector, including Mirna Therapeutics, Inc. and Bioo Scientific Corporation. His innovative approaches and research have positioned him as a key figure in the development of new therapeutic strategies.

Collaborations

Bader has collaborated with notable professionals in his field, including David Allen Brown and Jason F Wiggins. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Andreas Bader's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for innovative treatments in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…